nach oben

Erschienen in:

01.05.2015 | News item

Vemurafenib associated with sepsis

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

The WHO global individual case safety report (ICSR) database, Vigibase, contains 22 ISCRs of vemurafenib-associated sepsis, according to a report from Dr Geraldine Hill of the Uppsala Monitoring Centre.[1] Although metastatic cancer itself is a risk factor for sepsis, there is evidence to support a signal for vemurafenib-associated sepsis, with a consistent time to onset and vemurafenib being the only suspected drug in most cases. …

Hill G. Vemurafenib and Sepsis. WHO Pharmaceuticals Newsletter 2015: 32-35, No. 2, May 2015. Available from: URL: http://www.who.int/entity/medicines/publications/Pharm_Newsletter2_2015.pdf?ua=1

Roche. Response from Roche (re: Vemurafenib and Sepsis). WHO Pharmaceuticals Newsletter 2015: 35-36, No. 2, May 2015. Available from: URL: http://www.who.int/entity/medicines/publications/Pharm_Newsletter2_2015.pdf?ua=1

Titel: Vemurafenib associated with sepsis
Publikationsdatum: 01.05.2015
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-015-1770-8

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Vemurafenib associated with sepsis

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2015

Cetuximab

Peginterferon-α-2a

Cefepime

Potassium bromide

Triamcinolone

Cinacalcet